HPV Ends Here: Increasing Uptake of the HPV Vaccine

NARecruitingINTERVENTIONAL
Enrollment

2,232

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

December 31, 2026

Conditions
HPV Vaccine
Interventions
BEHAVIORAL

Intervention Arm

Within the intervention clinics, parents of patients between the ages of 10-12 (who are eligible for the HPV vaccine) will receive a culturally tailored customized HPV vaccine message and testimonial video from a patient/survivor of an HPV associated cancer (e.g., oropharyngeal, or cervical) via the MyChart patient portal. Parents will also receive a personal call from the research coordinator to remind them that their child is due for the HPV vaccine. If the parent is interested in scheduling the HPV vaccine appointment during this call, the research coordinator will transfer the parent to UC Davis appointment call center to schedule the appointment. Also, primary care team members will receive a semi-annual learn at lunch workshop focused on strategies to introduce the HPV vaccine to parents and how to address concerns from vaccine hesitant parents. Workshop content will be tailored/adapted to include patient/parent cultural considerations.

Trial Locations (1)

95817

RECRUITING

University of California Davis Health, Sacramento

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, Davis

OTHER